Advertisement
Screener

ACCELERON PHARMA INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

ACCELERON PHARMA INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

ACCELERON PHARMA INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$7.97 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.

Discontinued › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2014-11-07

  • ACCELERON PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2014-09-30 was -$7.97M.
  • ACCELERON PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2014-06-30 was -$16.55M, a 226.55% decline year-over-year.
  • ACCELERON PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2013-09-30 was -$18.51M.
  • ACCELERON PHARMA INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2013-06-30 was $13.08M.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month
2014-09-30-$7.97M
10-Q · filed 2014-11-07
-$24.52M
derived: sum of 2 quarters · filed 2014-11-07
-$33.64M
10-Q · filed 2014-11-07
2014-06-30-$16.55M
10-Q · filed 2014-08-12
-$25.67M
10-Q · filed 2014-08-12
2013-09-30-$18.51M
10-Q · filed 2014-11-07
-$5.43M
derived: sum of 2 quarters · filed 2014-11-07
-$3.79M
10-Q · filed 2014-11-07
2013-06-30$13.08M
10-Q · filed 2014-08-12
$14.72M
10-Q · filed 2014-08-12
2012-09-30-$7.21M
10-Q · filed 2013-11-14
-$22.20M
10-Q · filed 2013-11-14